Pfizer, BMS, AstraZeneca, GSK, Bayer To Discuss Latest Tactics And Strategies To Achieve Sale Excellence

Main Category: Pharma Industry / Biotech Industry
Article Date: 19 Feb 2008 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Eyeforpharma, the global source of information and education for the pharmaceutical industry, announced that the 6th annual Sales Force Effectiveness Summit, Philadelphia, 23-24 June 2008 has secured its full speaker faculty including leading executives from Pfizer, BMS, AstraZeneca, GSK, Bayer, Merck, Amylin, EMD Serono, Bayer, Eli Lilly & Company, Takeda, sanofi-avaentis

The full detailed brochure is available to download now here.

The conference comprises a carefully selected faculty of speakers, Keynotes include:

- Don Hribek, VP Strategic Accounts, EMD Serono/Merck
- Irwin Darack, Director Sales Excellence, Bristol-Myers Squibb
- Duke Garvin, Director Sales Excellence, Pfizer
- Mike Pucci, VP External Advocacy, GSK
- Elizabeth Sozanski, Senior Director of Marketing Strategy, AstraZeneca
- Christopher Leidli, District Sales Manager, Sanofi-Aventis
- Michael Castagna, Director Marketing, EMD Serono/Merck
- Jeremy Stamer, Director Business Analytics, Amylin
- Stan Metter, Metabolic Specialty District Manager, Takeda
- Doug Woolley, National Institutional Sales Director, Reliant GSK affiliate
- Michael Fowler, Virtual Sales Manager, Eli Lilly & Company
- Kenith Herbert, Director of Sales, Takeda
- Ken Liss, National Sales Director, Bayer

Irwin Darack, a Director of Sales Excellence at Bristol-Myers Squibb comments that "Driving Pharmaceutical Sales today, whether global brands or new product launches, requires a unique balance between allocation of sales force resources, customer segmentation, channel management, organizational competencies, and compliance to state, federal and international regulations. In today's dynamic environment a superior Sales Effectiveness program can mean the difference between a "block buster" and just another "alternative product". A Sales Effectiveness program must be based on T2MC, targeting, training, motivation and communication, to be successful."

"The Eye-For-Pharma Symposium is designed to help you build that competitively superior Sales Effectiveness program." Duke Garvin, Director Sales Excellence, Pfizer

The two day event taking place June 23-24 2008, Philadelphia comprises of presentation sessions, roundtables, workshops, a networking evening and an exhibition hall. Some of the topics to be explored are the current state of trust between consumers and the Pharma industry, the performance of first line managers, the success of Key Account Management and the best means to access physicians.

eyeforpharma is offering Early Bird discounts to those who secure their place at the Summit early, with $400 knocked off the price of tickets to anyone registering before March 14th, making the cost $1595 for a full Silver Pass.

Further updates, full information on presentations and speakers, and details on other ticket options can all be found by downloading the brochure here.

About Eyeforpharma

Eyeforpharma is a leading global source of information for the pharmaceutical industry. Our reputation has been built on quality, in-depth conferences that have distinguished themselves from competitors by the depth and breadth of research we put into each conference to ensure it is covering the hottest and most pertinent issues of the industry. Months are spent talking directly to senior executives in the industry, as well as relevant consultants and journalists and well respected solutions providers.

Eyeforpharma also provides a fortnightly newsletter to over 11 thousand leading executives from every major pharmaceutical company in the industry, and of course consultants, sponsors and academics as well.

The eyeforpharma wiki, launched last month, highlights our dedication to improving the communication between people in the industry and furthering learning and development within it.

http://www.eyeforpharma.com